SURAKSHA
NSESuraksha Diagnostic Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
₹264.30
0.90 (0.34%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.38K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
43.7
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Service Provider
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹224.1+17.9%
52W High₹333-20.6%
Current Price
₹264.30
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹211.44
Upper Circuit₹317.16
Reference Price
₹264.30
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹235.4
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹238.5
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -42.96 (SELL) with 50.3% confidence
10/20 Bearish Cross detected 1 day(s) ago
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
50%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
270.61
EMA50
275.18
EMA200
285.14
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹266.17
₹273.80
₹278.00
₹285.45
₹294.02
Support (Below)
₹255.00
₹251.50
₹247.05
₹240.00
₹224.10
Volume Analysis
TrendDECREASING
Change-29.90%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bearish Cross
1 day ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹261.66
3% Risk₹256.37
5% Risk₹251.09
7% Risk (Custom)
₹245.80Technical Levels
1x ATR (Volatility)₹254.26
2x ATR (Swing)₹244.22
3x ATR (Trend)₹234.18
Immediate Support₹255.00
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹65.1 Cr | ₹72.6 Cr | ₹78.7 Cr | ₹77.7 Cr |
| Net Profit | ₹7.4 Cr | ₹9.4 Cr | ₹9 Cr | ₹7.5 Cr |
| EPS | — | ₹1.80 | ₹1.73 | ₹1.44 |
| Operating Profit | ₹20 Cr | ₹24.7 Cr | ₹25 Cr | ₹23.8 Cr |
ROE
15.07%
ROCE
16.59%
Debt/Equity
0.42
Current Ratio
1.10
OPM
30.61%
NPM
9.68%
Peer Comparison
Healthcare Service ProviderPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Dr. Lal Path Labs Ltd. | ₹1,692.80 | +0.49% | 55.4 | ₹28.36K Cr small Cap | |
| Vijaya Diagnostic Centre Limited | ₹1,389.10 | +0.82% | 82.0 | ₹14.29K Cr small Cap | |
| Thyrocare Technologies Limited | ₹515.70 | -3.71% | 52.8 | ₹8.21K Cr small Cap | |
| Nephrocare Health Services Limited | ₹649.00 | +2.46% | — | ₹6.51K Cr small Cap | |
| Metropolis Healthcare Limited | ₹567.95 | +1.41% | 60.7 | ₹2.94K Cr small Cap | |
| Krsnaa Diagnostics Limited | ₹556.65 | -0.04% | 17.8 | ₹1.81K Cr small Cap | |
| Suraksha Diagnostic Limited | ₹264.30 | +0.34% | 43.7 | ₹1.38K Cr small Cap | |
| Health X Platform Limited | ₹323.30 | -1.93% | 34.1 | ₹1.03K Cr small Cap | |
| 3B Blackbio Dx Limited | ₹1,148.60 | -1.64% | — | ₹986 Cr small Cap | |
| Chandan Healthcare Limited | ₹249.65 | -1.75% | 21.8 | ₹610 Cr small Cap | |
| Invicta Diagnostic Limited | ₹69.00 | -0.58% | — | ₹87 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SURAKSHA
View AllNEWS
positive
Business Standard - Markets 50d ago
Suraksha Diagnostic consolidated net profit declines 15.02% in the March 2026 quarter
Sales rise 25.07% to Rs 81.41 crore
SURAKSHAHealthcare
positive
ET Markets - Industry 64d ago
Jan Suraksha revamp: PMJJBY, PMSBY, APY may see increase in sum insured
The government is contemplating a substantial expansion of insurance benefits within its renowned Jan Suraksha initiatives. This strategy is designed to bolster social safety nets for low-income families and informal sector workers.
SURAKSHAHealthcare
positive
CNBC TV18 - Markets 66d ago
SEBI cautions market players on risks from AI tools like Mythos; sets up task force
SEBI warns on AI driven cyber risks, forms cyber-suraksha.ai task force to assess tools like Mythos and strengthen cybersecurity for market participants.
SURAKSHAHealthcare